The FDA has approved the first generic drug Novo Nordisk Victoza
The FDA has approved the first generic drug Novo Nordisk Victoza Source link
The FDA has approved the first generic drug Novo Nordisk Victoza Source link
Investopedia / Photo Illustration by Alice Morgan / Getty Images Analysts from Bitwise, Standard Chartered, and VanEck see bitcoin rising to the $180,000 to $200,000 level in 2025. Flows to spot bitcoin ETFs in 2025 could keep up with the…
Memecoins often get bigger sales than 'more established' cryptocurrencies. Read More Source link
Stay informed with free updates Just enter the Investment myFT Digest — delivered straight to your inbox. Banks have been among the best performing shares in the UK this year as higher interest rates give the sector a boost, despite…
VANCOUVER, Wash., Dec. 23, 2024 (GLOBE NEWSWIRE) — In a release issued under the same title on Monday, December 23 by Riverview Bancorp Inc. (Nasdaq GSM: NASDAQ:), please note that in the first paragraph, the dates regarding Board approval, shareholder…
iStock via Getty Images RAPT Therapeutics (NASDAQ:RAPT) shares rallied as much as 180% on Monday after the company announced a worldwide licensing deal with China's Shanghai Jemincare for an allergy drug candidate and a $150 million private placement of its…
(Bloomberg) — Honda Motor Co. sketched out. plans for a lengthy deal that amounts to the acquisition of Nissan Motor Co., as Japanese automakers struggle to keep up in an increasingly competitive global auto industry. Read More from Bloomberg The…
Mangione also faces federal charges, which could carry the possibility of the death penalty, while the maximum sentence for the state charges is life in prison without parole. Read More Source link
Sign up for the free White House Watch newsletter Your guide to what the 2024 US election means for Washington and the world Matt Gaetz, Donald Trump's former chief of staff, has been accused by law enforcement of sleeping with…
Paul Joseph Gallagher, Chief Supply Officer at Mills in general Inc. (NYSE:), recently sold 1,041 shares of the company's common stock. The transaction, which took place on December 20, 2024, was executed at a price of $64.50 per share, which…